Target intelligence / Profile preview

PLAC1 antisense RNA 1 (PLAC1-AS1)

Target
PLAC1-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Non-protein-coding RNA
01

Overview

PLAC1 antisense RNA 1 (PLAC1-AS1) is a long non-coding RNA gene transcribed from the antisense strand adjacent to the PLAC1 coding region. As a non-coding RNA, it likely functions in the post-transcriptional and/or epigenetic regulation of gene expression, possibly modulating PLAC1 mRNA levels or other nearby loci. There is no evidence to date that PLAC1-AS1 encodes a protein or serves as a classical therapeutic target such as a receptor, enzyme, or transporter. The functional role and disease associations of PLAC1-AS1 have not been extensively studied, but by analogy to other antisense lncRNAs, it may play roles in transcriptional regulation, chromatin state modulation, or RNA stability. Current genetic and biomedical databases do not report direct drug interactions, mechanisms of action for drugs, or use as a clinical biomarker[3]. PLAC1-AS1 is not classified as a receptor, enzyme, transporter, or drug target based on current literature and genetic resources[3]. The designation "antisense RNA 1" clearly places it in the class of non-protein-coding regulatory RNA molecules. If more detailed functional or disease association data for PLAC1-AS1 becomes available, it may clarify its possible roles in gene regulation or pathology. Currently, however, its primary identity remains as a lncRNA of uncertain but potentially regulatory function.

Other names
PLAC1-AS1PLAC1 Antisense RNA 1
02

Mechanism of action

None established for drug targeting, as no drugs currently target PLAC1-AS1

03

Biological functions

Regulation of gene expression (possible regulation of PLAC1 expression)Other (potential involvement in cancer-related processes by modulating gene regulatory networks, although direct evidence is limited)
04

Disease associations

Other (specifically, associations with cancer are possible but not well established or consistently reported based on currently available data)

Beyond the preview

Go deeper on PLAC1 antisense RNA 1 (PLAC1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLAC1 antisense RNA 1 (PLAC1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call